Cedarus Sinai studies show a new way to reduce heart loss and heart attack.
New research by researchers at Cedarus Sena shows a modern way to help patients suffer more quickly. This new method uses a technique that promotes the body’s natural capacity that develops some immune cells that reduce inflammation and accelerate healing. Heart attacks, which occur when the blood flow to the heart is blocked, is affected by more than 800,000 people every year in the United States and is an important cause of death. Although medical developments have improved survival rates, many people who avoid heart attacks still face complications from inflammation, which can lead to heart failure.
Inflammation after heart attack is one of the biggest challenges facing doctors when treating these patients. In many cases, the body’s immune system is very high, which damages the heart and weakens the ability to pump blood effectively. Researchers at Cedarus Sena focused on the issue by trying to find a way to prevent the immune system from abusing the system. Their solution was to increase the number of regulatory T cells, or triggers, which help maintain the immune system and prevent it from causing too much harm.
Generally, most of them need to be removed in the patient’s body to get them into the body, increase them into the lab, and then return to the patient. However, it takes a lot of time to use the process during a heart attack, which requires immediate intervention. As a result, the Cedarus Sena team decided to find a fast way to increase the natural production of the body’s triggers.
They found that the cells of cells issued by the cells – small bags could be provided with a molecule called BCYRN1, which helps to increase the production of these supportive immune cells. When the team injected the vessels in the rats which had just suffered a heart attack, they saw the hopeful results. The rats who received the vases had more triggers in their hearts, less inflammation, and less damage to the heart than those who did not get treatment. Their hearts also maintained their potential for pumping, which is the key to preventing long -term heart failure.
Extra cellular vascular used in the study was developed by cardi spare cells (CDC), which are heart cells that can be used to help repair heart tissues. These cells are special because they naturally have a high amount of BCYRN1. Using the CDC to make vascular, researchers managed to provide BCYRN1 quickly in the heart of the rats after their heart attack.
Although this study was done in mice, researchers believe that the same technique can be molded to help human patients. Possible requests for this discovery are beyond a heart attack. This procedure can also be used to treat other diseases, which contains inflammation, such as leopards or organ transplantation. Researchers hope that this approach can lead to new treatment for these conditions in the future.
Cedarus Sena research can be a game changer in which we treat heart attacks. This is an example of how science is seeing its own body system to find new ways to fix itself. By increasing the body’s immune response, it is possible to repair heart loss more efficiently, reduce the risk of heart failure, and improve the lives of people who avoid heart attack. When research is moving forward, it can pave the way for a safe, faster treatment that helps more people recover from heart attacks and other inflammatory diseases.
Sources:
Cedarus Sinai Study Cell Therapy rapid healing of heart loss
JCI-Towel Non-coding RNA B CRN1 promotes cardio protection by enhancing human and Maurin Regulatory T cell dynamics
